People aged 16 and over who receive blood tests in A&E at Leeds General Infirmary and St James's University Hospital are now ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

Goldman Sachs downgraded Dynavax to Sell, citing increased competition in the shingles vaccine market and uncertainty over hepatitis B revaccination demand.

Bluejay's lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).

The UK government has announced that it is renewing funding for the public health campaign HIV Prevention England for another year as part of efforts to end HIV transmission by 2030. The programme, ...

Aligos currently expects to use the net proceeds from the private placement, together with its existing cash, cash ...

The Iowa City Community School District School Board met Tuesday and reviewed reports continuing the conversation about ...

Two sexually transmitted infections are spreading faster than ever. Our expert guide tells you everything you need to know, ...

A recent research study has identified hypertension as the leading prevalent non-communicable disease (NCD) in Khyber ...

Fintel reports that on February 11, 2025, Goldman Sachs downgraded their outlook for Dynavax Technologies (NasdaqGS:DVAX) ...

Many readers wrote to express their strong opposition to Robert F. Kennedy Jr.’s nomination to head the Department of Health and Human Services, which this week cleared a Senate committee vote and ...